Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;54(8):6006-6017.
doi: 10.1007/s12035-016-0111-0. Epub 2016 Sep 30.

Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke

Affiliations
Review

Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke

Rongrong Zhang et al. Mol Neurobiol. 2017 Oct.

Abstract

Stroke is one of the leading causes of death and disability in the world. Oxidative stress, which refers to an excessive generation of reactive oxygen species (ROS), plays a key role in the pathological process of stroke. Excessive ROS production contributes to brain ischemia/reperfusion injury through many mechanisms including BBB disruption, inflammation, apoptosis, and cellular necrosis. Nuclear factor-E2-related factor 2 (Nrf2) is one of the critical regulators of endogenous antioxidant defense, which promote the transcription of a wide variety of antioxidant genes. Emerging evidence has demonstrated that activation of Nrf2 and its target genes may protect the brain against ischemia/reperfusion injury, and therapies aimed at increasing Nrf2 activity appear to be beneficial to alleviate brain injury in stroke through the suppression of oxidative stress. The main purpose of this review is to discuss the current evidence for the role of Nrf2 in stroke and the potential interventions to enhance Nrf2 activation to attenuate stroke-induced injury.

Keywords: Antioxidants; Nrf2; Reactive oxygen species; Stroke.

PubMed Disclaimer

References

    1. Brain Res Bull. 2014 Oct;109 :61-7 - PubMed
    1. FEBS J. 2008 Jul;275(13):3278-89 - PubMed
    1. Methods Enzymol. 2004;382:115-44 - PubMed
    1. Int J Dev Neurosci. 2014 Nov;38:79-86 - PubMed
    1. Mol Neurobiol. 2016 Jul;53(5):3154-3167 - PubMed

Publication types

Substances

LinkOut - more resources